Fennec Pharmaceuticals Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
35.0M
on 2026-06-30, from 27.1M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
111K
Warrants of every class as tagged in the XBRL facts on 2025-09-30, exercise price $8.00. 10-Q ↗
Cash
80.9 quarters
$41.2M on 2026-06-30 ÷ $510K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-11-18 | Public offering | 670,000 | $7.50 | $5.0M | 424B5 ↗ |
| 2025-11-17 | Public offering | 4,666,667 | $7.50 | $35.0M | 424B5 ↗ |
Also on file: $13.0M convertible notes, 2024-12-18 8-K ↗ · $13.0M convertible notes, 2025-11-13 8-K ↗